These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 16945672)

  • 1. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
    Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
    J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P; Kutasy B; Colhoun E; Hunziker M
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
    Hunziker M; Mohanan N; Puri P
    J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
    Friedmacher F; Colhoun E; Puri P
    J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic treatment for high grade vesicoureteral reflux in infants.
    Dawrant MJ; Mohanan N; Puri P
    J Urol; 2006 Oct; 176(4 Pt 2):1847-50. PubMed ID: 16945670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
    Yu RN; Roth DR
    Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.
    Puri P; Chertin B; Velayudham M; Dass L; Colhoun E
    J Urol; 2003 Oct; 170(4 Pt 2):1541-4; discussion 1544. PubMed ID: 14501655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children.
    Oswald J; Riccabona M; Lusuardi L; Bartsch G; Radmayr C
    Urology; 2002 Nov; 60(5):894-7; discussion 898. PubMed ID: 12429323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid.
    Puri P; Mohanan N; Menezes M; Colhoun E
    J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
    Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
    Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children.
    Cerwinka WH; Scherz HC; Kirsch AJ
    J Urol; 2007 Oct; 178(4 Pt 1):1469-73. PubMed ID: 17706704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success.
    Lavelle MT; Conlin MJ; Skoog SJ
    Urology; 2005 Mar; 65(3):564-7. PubMed ID: 15780377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
    Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
    J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
    Moore K; Bolduc S
    J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy.
    Kitchens D; Minevich E; DeFoor W; Reddy P; Wacksman J; Sheldon C; Koyle M
    J Urol; 2006 Oct; 176(4 Pt 2):1861-3. PubMed ID: 16945674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
    Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
    J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.
    Traxel E; DeFoor W; Reddy P; Sheldon C; Minevich E
    J Urol; 2009 Oct; 182(4 Suppl):1708-12. PubMed ID: 19692024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
    Stenberg A; Larsson E; Läckgren G
    J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
    Kobelt G; Canning DA; Hensle TW; Läckgren G
    J Urol; 2003 Apr; 169(4):1480-4; discdussion 1484-5. PubMed ID: 12629396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.